218 related articles for article (PubMed ID: 29151902)
1. Coexistence of p210
Wang YY; Ding WJ; Jiang F; Chen ZX; Cen JN; Qi XF; Liang JY; Liu DD; Pan JL; Chen SN
Oncol Lett; 2017 Nov; 14(5):5171-5178. PubMed ID: 29151902
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and laboratory characteristics of 12 Ph/BCR-ABL positive acute myeloid leukemia patients].
Cai W; He X; Chen S; Sun A; He J; Zhu M; Wu D
Zhonghua Xue Ye Xue Za Zhi; 2015 May; 36(5):398-402. PubMed ID: 26031527
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of inversion 16 and the Philadelphia chromosome in acute and chronic myeloid leukemias : report of six cases and review of literature.
Wu Y; Slovak ML; Snyder DS; Arber DA
Am J Clin Pathol; 2006 Feb; 125(2):260-6. PubMed ID: 16393682
[TBL] [Abstract][Full Text] [Related]
4. [Detection of common fusion transcript levels in untreated leukemia patients by real-time quantitative RT-PCR technique].
Qin YZ; Li JL; Zhu HH; Li LD; Chang Y; Le H; Ruan GR; Liu YR; Huang XJ; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):433-7. PubMed ID: 18072623
[TBL] [Abstract][Full Text] [Related]
5. Coexistence of inversion 16 and the Philadelphia chromosome comprising P190 BCR/ABL in chronic myeloid leukemia blast crisis.
Ninomiya S; Kanemura N; Tsurumi H; Kasahara S; Hara T; Yamada T; Moriwaki H
Int J Hematol; 2011 Jun; 93(6):806-810. PubMed ID: 21523337
[TBL] [Abstract][Full Text] [Related]
6. Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report.
Zhang W; Wang H; Zhang P; Li H; Ma X; Liu H
Braz J Med Biol Res; 2021; 54(12):e11605. PubMed ID: 34730684
[TBL] [Abstract][Full Text] [Related]
7. BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features.
Neuendorff NR; Burmeister T; Dörken B; Westermann J
Ann Hematol; 2016 Aug; 95(8):1211-21. PubMed ID: 27297971
[TBL] [Abstract][Full Text] [Related]
8. BCR/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML).
Arana-Trejo RM; Ruíz Sánchez E; Ignacio-Ibarra G; Báez de la Fuente E; Garces O; Gómez Morales E; Castro Granados M; Ovilla Martínez R; Rubio-Borja ME; Solís Anaya L; Herrera P; Delgado Llamas J; Kofman S
Clin Lab Haematol; 2002 Jun; 24(3):145-50. PubMed ID: 12067277
[TBL] [Abstract][Full Text] [Related]
9. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
[TBL] [Abstract][Full Text] [Related]
10. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
Elmaagacli AH; Beelen DW; Kroll M; Trzensky S; Stein C; Schaefer UW
Bone Marrow Transplant; 1998 Jan; 21(2):159-66. PubMed ID: 9489633
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence in situ hybridization: a highly efficient technique of molecular diagnosis and predication for disease course in patients with myeloid leukemias.
Amare PS; Baisane C; Saikia T; Nair R; Gawade H; Advani S
Cancer Genet Cytogenet; 2001 Dec; 131(2):125-34. PubMed ID: 11750052
[TBL] [Abstract][Full Text] [Related]
12. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.
Li S; Ilaria RL; Million RP; Daley GQ; Van Etten RA
J Exp Med; 1999 May; 189(9):1399-412. PubMed ID: 10224280
[TBL] [Abstract][Full Text] [Related]
13. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
[TBL] [Abstract][Full Text] [Related]
14. Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia.
Marcucci G; Caligiuri MA; Döhner H; Archer KJ; Schlenk RF; Döhner K; Maghraby EA; Bloomfield CD
Leukemia; 2001 Jul; 15(7):1072-80. PubMed ID: 11455976
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation.
Román J; Alvarez MA; Torres A
Haematologica; 2000 Oct; 85(10):1072-82. PubMed ID: 11025600
[TBL] [Abstract][Full Text] [Related]
16. Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.
Salem A; Loghavi S; Tang G; Huh YO; Jabbour EJ; Kantarjian H; Wang W; Hu S; Luthra R; Medeiros LJ; Khoury JD
Am J Hematol; 2017 Jun; 92(6):520-528. PubMed ID: 28253536
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of P190 and P210 BCR/ABL transcripts in chronic myeloid leukemia blast crisis resistant to imatinib.
Junmei Z; Fengkuan Y; Yongping S; Baijun F; Yuzhang L; Lina L; Qinglan Z
Springerplus; 2015; 4():170. PubMed ID: 25897414
[TBL] [Abstract][Full Text] [Related]
18. De Novo Acute Myeloid Leukemia with Combined
Sethapati VR; Jabr R; Shune L; El Atrouni W; Gonzales PR; Cui W; Golem S
Case Rep Hematol; 2020; 2020():8822670. PubMed ID: 33489389
[TBL] [Abstract][Full Text] [Related]
19. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
20. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.
Wetzler M; Talpaz M; Van Etten RA; Hirsh-Ginsberg C; Beran M; Kurzrock R
J Clin Invest; 1993 Oct; 92(4):1925-39. PubMed ID: 8408645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
